Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial
Background Standardization of surgical and pathologic techniques is crucial to the
interpretation of studies evaluating adjuvant therapies for pancreatic cancer (PC). Methods …
interpretation of studies evaluating adjuvant therapies for pancreatic cancer (PC). Methods …
EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer …
Background: Cetuximab has shown significant clinical activity in metastatic colon cancer.
However, cetuximab-containing neoadjuvant chemoradiation has not been shown to …
However, cetuximab-containing neoadjuvant chemoradiation has not been shown to …
Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer
JCT Wong, SK Chan, DF Schaeffer, X Sagaert… - Clinical Cancer …, 2011 - AACR
Purpose: Treatments for colorectal cancer (CRC) are primarily disease stage based.
However, heterogeneity in outcome within even a single stage highlights its limitations in …
However, heterogeneity in outcome within even a single stage highlights its limitations in …
[PDF][PDF] Rezultate æi factori de prognostic în cancerul rectal operat cu intenåie curativã–experienåa unui centru teråiar
chirurgia 3 dab_c 4'2006 a.qxd Page 1 Rezumat Introducere: cancerul de rect are un prognostic
paradoxal la aproximativ 25% dintre pacienåi, deæi parametrii intraoperatori æi stadiul …
paradoxal la aproximativ 25% dintre pacienåi, deæi parametrii intraoperatori æi stadiul …
Updates on Rectal Cancer
In the last few decades there has been a shift in the paradigm of rectal cancer treatment.
Surgery, historically the only weapon against rectal malignances, has found valuable allies …
Surgery, historically the only weapon against rectal malignances, has found valuable allies …